Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI
Cancer medicine, 2019.
MR imagingT2 signalaggressive fibromatosisdesmoid fibromatosismethotrexate/vinorelbine chemotherapyMore(1+)
Low-dose MTX/VNL for a defined duration has high efficacy with sustained benefit and minimal toxicity for treating DF. V and T2 signal might better predict treatment response than RECIST.
Full Text (Upload PDF)
PPT (Upload PPT)